MedPath

Efficacy of hangekobokuto, a representative Kampo (Japanese herbal medicine) formula for Ki congestion, in overactive bladder: A Randomized, Double-blind, Placebo-Controlled Trial.

Phase 4
Conditions
Overactive bladder
Registration Number
JPRN-UMIN000000751
Lead Sponsor
Oriental Medicine Research Center, Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
98
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients currently taking any Kampo medicine 2.Patients having taken any Kampo medicine in the past 4 weeks 3.Patients with clinically significant liver or renal dysfunction 4.Patients with some diseases which might influence their general condition, for example, cancer or heart failure 5.Patients considered inappropriate for this trial by the physicians-in-charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OABSS(Overactive Bladder Symptom Score), KHQ(King's Health Questionnaire), SF-36 (MOS Short-Form 36-Item Health Survey), IPSS(International Prostate Symptom Score)(mele only)
Secondary Outcome Measures
NameTimeMethod
urine flow, residual urine volume, PSA(prostate specific antigen), pupillary light reflex, Kampo findings, adverse events
© Copyright 2025. All Rights Reserved by MedPath